WallStreetZenWallStreetZen

NASDAQ: SGMO
Sangamo Therapeutics Inc Stock Ownership - Who owns Sangamo Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Sangamo Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Nathalie DuboisstringfellowSVP-CHIEF DEVELOPMENT OFFICER2024-02-255,010$1.13
$5.66kSell
Amy PoolerVP HEAD OF RESEARCH2024-02-252,459$1.13
$2.78kSell
Scott B. WilloughbySVP GEN. COUNSEL SECRETARY2024-02-253,453$1.13
$3.90kSell
Sandy MacRaePRESIDENT CEO AND DIRECTOR2024-02-2524,157$1.13
$27.30kSell
Prathyusha DuraibabuSVP CHIEF FINANCIAL OFFICER2024-02-253,453$1.13
$3.90kSell
Scott B. WilloughbySVP GEN. COUNSEL SECRETARY2024-02-244,379$1.13
$4.95kSell
Sandy MacRaePRESIDENT CEO AND DIRECTOR2024-02-2416,115$1.13
$18.21kSell
Nathalie DuboisstringfellowSVP-CHIEF DEVELOPMENT OFFICER2024-02-245,474$1.13
$6.19kSell
Amy PoolerVP HEAD OF RESEARCH2024-02-242,209$1.13
$2.50kSell
Prathyusha DuraibabuSVP CHIEF FINANCIAL OFFICER2024-02-245,474$1.13
$6.19kSell

1 of 4

SGMO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMO insiders and whales buy or sell their stock.

SGMO Shareholders

What type of owners hold Sangamo Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Biogen Inc9.87%17,652,466$9.11MInsider
Blackrock Inc7.88%14,095,865$7.27MInstitution
Vanguard Group Inc7.04%12,599,129$6.50MInstitution
Wasatch Advisors LP6.93%12,397,924$6.40MInstitution
Acadian Asset Management LLC2.66%4,750,875$2.45MInstitution
D E Shaw Co Inc2.62%4,683,973$2.42MInstitution
Ra Capital Management LP2.06%3,683,002$1.90MInsider
Geode Capital Management LLC1.79%3,206,310$1.65MInstitution
Renaissance Technologies LLC1.76%3,145,878$1.62MInstitution
State Street Corp1.51%2,708,368$1.40MInstitution

1 of 3

SGMO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMO48.59%17.99%Net SellingNet Selling
MIST33.44%24.16%
SLS6.21%13.47%Net Selling
MCRB59.28%30.14%Net SellingNet Selling
ALVR14.62%85.38%Net BuyingNet Selling
View Top Biotech Stocks

Sangamo Therapeutics Stock Ownership FAQ

Who owns Sangamo Therapeutics?

Sangamo Therapeutics (NASDAQ: SGMO) is owned by 48.59% institutional shareholders, 17.99% Sangamo Therapeutics insiders, and 33.42% retail investors. Biogen Inc is the largest individual Sangamo Therapeutics shareholder, owning 17.65M shares representing 9.87% of the company. Biogen Inc's Sangamo Therapeutics shares are currently valued at $8.56M.

If you're new to stock investing, here's how to buy Sangamo Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.